Cypress Advisory Group’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$228K Hold
3,300
0.18% 66
2025
Q1
$229K Hold
3,300
0.21% 58
2024
Q4
$284K Buy
+3,300
New +$284K 0.26% 54